Bio-Techne (TECH) Treasury Shares (2009 - 2025)
Bio-Techne (TECH) recorded quarterly Treasury Shares of $831000.0 in Q2 2025, up 67.2% quarter-over-quarter from $497000.0 in Q2 2024, and up 67.2% on a YoY basis from $497000.0 in Q2 2024.
Bio-Techne (TECH) Treasury Shares (2009 - 2025) Analysis & Trends
Bio-Techne's Treasury Shares history runs 16 years deep, the most recent figure standing at $831000.0 for Q2 2025.
- In Q2 2025, Treasury Shares rose 67.2% year-over-year to $831000.0; the TTM figure through Jun 2025 stood at $831000.0 (up 67.2% YoY), while the FY2025 annual figure was $831000.0, up 67.2% from the prior year.
- Treasury Shares was $831000.0 for Q2 2025 at Bio-Techne, up from $497000.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $1.4 million in Q4 2023 to a low of $37000.0 in Q2 2023.
- Historically, Treasury Shares has averaged $445700.0 across 5 years, with a median of $342000.0 in 2021.
- The sharpest annual moves came in 2023 and 2024: Treasury Shares slumped 87.75% in 2023, then jumped 1243.24% in 2024.
- A 5-year view of Treasury Shares shows it stood at $89000.0 in 2021, then soared by 149.44% to $222000.0 in 2022, then surged by 529.28% to $1.4 million in 2023, then plunged by 64.42% to $497000.0 in 2024, then surged by 67.2% to $831000.0 in 2025.
- The last three Treasury Shares figures came in at $831000.0 (Q2 2025), $497000.0 (Q2 2024), and $1.4 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Bio-Techne | 9.04 Bn | 8.83 Bn | 208.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 831,000.00 |
| Jun 30, 2025 | 831,000.00 |
| Jun 30, 2024 | 497,000.00 |
| Jun 30, 2024 | 497,000.00 |
| Dec 31, 2023 | 1.40 Mn |
| Dec 31, 2023 | 1.40 Mn |
| Jun 30, 2023 | 37,000.00 |
| Jun 30, 2023 | 37,000.00 |
| Sep 30, 2022 | 222,000.00 |
| Sep 30, 2022 | 222,000.00 |
| Jun 30, 2022 | 302,000.00 |
| Jun 30, 2022 | 302,000.00 |
| Mar 31, 2022 | 580,000.00 |
| Mar 31, 2022 | 580,000.00 |
| Dec 31, 2021 | 89,000.00 |
| Dec 31, 2021 | 89,000.00 |
| Jun 30, 2021 | 382,000.00 |
| Jun 30, 2021 | 382,000.00 |
| Mar 31, 2021 | 120,000.00 |
| Mar 31, 2021 | 120,000.00 |